photosensitivity disease: Photosensitivity refers to various symptoms, diseases and conditions caused or aggravated by exposure to sunlight.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
277 |
4. Check minimum number of eventsNone |
277 |
5. Include endpointsNone |
277 |
6. Filter based on genotype QC (FinnGen only) |
266 |
Control definitions (FinnGen only)
- Control exclude
- L12_RADIATIONRELATEDSKIN
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L57
- Name in latin
- Cutis laxa senilis
Similar endpoints
↥List of similar endpoints to
Cutis laxa senilis
based on the number of shared cases.
Similar with more cases:
- Skin changes due to chronic exposure to nonionizing radiation
- Radiation-related disorders of the skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1483 | 1319 | 155 |
| Only index persons | 1385 | 1244 | 141 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.00 |
| Only index persons | 0.04 | 0.05 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 55.73 | 54.96 | 62.05 |
| Only index persons | 55.47 | 54.72 | 62.05 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 266 | 242 | 24 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.01 |
| Median age at first event (years) | 56.18 | 55.40 | 64.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 277
- Matched controls
- 2770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L57.4
ICD-10 Finland
Cutis laxa senilis
+∞
307.7
257
*
QAJ30
NOMESCO Finland
Other facelift
522.2
81.4
77
*
QBJ30
NOMESCO Finland
Correction of abdominal apron
310.5
72.0
70
*
H02.3
ICD-10 Finland
Blepharochalasis
5.7
25.8
55
116
9862
FHL
Facial skin shaping surgery (Faclift)
+∞
23.2
22
*
7018B
ICD-9 Finland
Other hypertrophic and atrophic conditions of skin, Other specified hypertrophic and atrophic conditions of skin[ELASTOSIS SENILIS]
+∞
21.1
20
*
L57.0
ICD-10 Finland
Actinic keratosis
5.7
19.5
39
77
E66.8
ICD-10 Finland
Other obesity
5.7
19.2
39
78
QBJ00
NOMESCO Finland
Liposuction in trunk
23.8
15.8
22
10
J01DB01
ATC
cefalexin; oral
4.3
11.3
255
2020
Z41.1
ICD-10 Finland
Other plastic surgery for unacceptable cosmetic appearance
29.4
10.8
14
5
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.3
10.6
153
964
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
+∞
10.5
10
*
A02BC05
ATC
esomeprazole; systemic
2.3
10.4
149
932
J01EA01
ATC
trimethoprim; systemic
2.3
9.7
116
668
QAJ15
NOMESCO Finland
Browlift using video-endoscope
103.4
9.5
10
*
E66.01
ICD-10 Finland
Obesity due to excess calories
3.2
9.2
40
140
N06AB10
ATC
escitalopram; oral
2.4
9.0
77
382
P06
ICPC
Sleep disturbance
2.8
8.6
47
187
J02AC01
ATC
fluconazole; systemic
2.1
8.4
150
996
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
+∞
8.4
8
*
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
15.1
8.3
13
9
N06AB04
ATC
citalopram; systemic
2.2
8.1
84
452
H02BX01
ATC
methylprednisolone, combinations; systemic
3.7
7.9
26
76
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.7
7.8
47
197
QAJ10
NOMESCO Finland
Browlift
46.3
7.8
9
*
CBJ50
NOMESCO Finland
Operation for ptosis of eyebrow
19.0
7.7
11
6
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
9.8
7.4
14
15
XKC03
NOMESCO Finland
Water cystometry
4.5
7.3
18
42
QBJ05
NOMESCO Finland
Other correction of loose or redundant skin of trunk
+∞
7.3
7
*
M62.0
ICD-10 Finland
Diastasis of muscle
+∞
7.3
7
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
7.3
119
755
L03
ICPC
Low back symptom/complaint
2.1
7.2
100
598
N02BF01
ATC
gabapentin; oral
2.8
7.1
39
155
N05BA12
ATC
alprazolam; oral
2.6
7.1
45
193
WX402
NOMESCO Finland
General anaesthesia
2.2
7.0
71
375
SAA04
NOMESCO Finland
Special examination of mouth
3.6
7.0
24
72
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
7.0
45
195
N06AB03
ATC
fluoxetine; oral
2.5
6.9
50
228
TQW99
NOMESCO Finland
Other minor procedure on skin
3.8
6.9
21
58
E66.9
ICD-10 Finland
Obesity, unspecified
3.9
6.8
20
54
M54.5
ICD-10 Finland
Low back pain
1.9
6.7
118
764
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.9
6.6
33
125
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.0
6.6
88
516
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
6.0
6.6
17
30
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
6.5
73
401
N05CF01
ATC
zopiclone; oral
1.9
6.5
113
726
N02AX02
ATC
tramadol; systemic, rectal
1.9
6.5
135
921
QAJ05
NOMESCO Finland
Other correction of loose or redundant skin of head or neck
+∞
6.3
6
*
QAJ00
NOMESCO Finland
Liposuction in head or neck
+∞
6.3
6
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.4
6.3
47
218
S29
ICPC
Skin symptom/complaint other
2.1
6.1
67
364
SFA00
NOMESCO Finland
Small restoration
2.3
6.1
48
228
U71
ICPC
Cystitis/urinary infection other
2.7
6.0
33
131
J01DA01
ATC
[U] cefalexin
1.9
6.0
190
1469
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
115
742
1.94
6.53
2.1
1.9
116.29
146.36
u/l
1.09
110
694
156
1125
1.89
6.21
2.4
2.5
—
—
—
0
0
221
1822
2.05
5.50
4.8
4.1
11.40
12.57
mm/h
0.64
212
1651
152
1114
1.81
5.49
5.3
5.1
1.21
1.22
mmol/l
1.69
139
1005
140
1017
1.76
5.08
2.3
2.0
89.57
97.72
pmol/l
1.19
67
482
112
764
1.78
5.04
2.5
2.2
53.58
55.49
u/l
0.38
106
703
159
1213
1.73
4.72
6.3
5.9
1.22
1.23
mmol/l
1.10
144
1030
175
1388
1.71
4.36
4.6
4.0
6.23
6.60
mmol/l
1.85
164
1288
221
1878
1.87
4.27
7.8
7.0
72.44
78.15
u/l
1.68
212
1741
66
401
1.85
4.26
3.0
2.6
0.85
1.26
e6/l
0.73
43
217
188
1531
1.71
4.14
3.4
2.9
35.69
44.34
u/l
1.74
176
1425
59
352
1.86
4.02
3.3
2.8
0.81
0.81
mmol/l
0.01
54
323
225
1938
1.86
3.96
4.7
4.3
14.71
14.83
pmol/l
0.34
212
1754
30
143
2.23
3.75
1.9
1.3
—
—
—
0
0
46
260
1.92
3.68
2.3
2.2
5.67
6.91
umol/l
0.43
41
222
82
555
1.68
3.59
1.4
1.3
6.03
2.19
u/ml
0.32
15
144
252
2280
2.17
3.47
5.9
5.2
1.85
2.39
mu/l
0.50
241
2076
58
364
1.75
3.32
3.2
2.7
3.63
3.67
e6/l
0.01
35
180
134
1043
1.55
3.22
4.9
3.6
35.54
35.48
g/l
0.04
127
973
170
1401
1.55
3.12
3.4
3.0
—
—
—
0
0
39
221
1.89
3.10
2.0
1.7
362.26
372.44
nmol/l
0.11
39
197
47
285
1.78
3.02
11.3
6.9
—
—
—
0
0
58
379
1.67
2.85
1.9
1.9
—
—
—
0
0
82
589
1.56
2.74
1.6
1.5
30.03
22.27
nmol/l
0.72
72
487
134
1076
1.48
2.61
2.5
2.2
83.43
79.30
nmol/l
0.80
121
932
80
579
1.54
2.57
1.8
2.2
—
—
—
0
0
26
137
1.99
2.56
1.8
1.8
—
—
—
0
0
33
189
1.85
2.55
4.5
5.7
1.20
1.31
mmol/l
0.36
33
181
46
292
1.69
2.52
5.1
4.7
36.14
32.68
%
1.00
28
181
130
1044
1.46
2.50
2.9
2.7
137.96
96.57
ug/l
0.41
124
941
135
1106
1.43
2.27
14.0
12.6
1.16
1.20
inr
0.15
27
330
114
907
1.44
2.24
3.1
3.6
15.08
37.91
ng/l
2.27
84
630
265
2507
2.32
2.22
19.6
16.0
70.00
71.26
umol/l
0.58
265
2507
105
827
1.43
2.16
3.6
3.0
—
—
—
0
0
254
2372
1.85
2.16
17.3
13.6
21.21
21.67
mg/l
0.08
207
1849
64
458
1.52
2.14
4.1
3.7
257.43
204.84
ng/l
0.08
55
357
41
264
1.65
2.14
1.8
1.9
—
—
—
0
0
86
657
1.45
2.07
3.4
2.9
0.14
0.59
e6/l
3.75
69
484
91
706
1.43
2.01
2.6
2.8
1021.10
1110.07
ng/l
0.11
75
598
13
57
2.34
2.01
1.3
1.4
—
—
—
0
0
40
263
1.61
1.93
1.8
1.8
—
—
—
0
0
73
550
1.44
1.88
1.5
1.7
0.73
1.03
mg/l
1.09
58
447
8
28
2.91
1.87
2.0
3.0
13.25
13.28
%
—
8
28
251
2358
1.69
1.78
5.1
4.6
5.77
5.90
mmol/l
0.87
235
2133
8
30
2.71
1.73
1.5
1.4
—
—
—
0
0
8
30
2.71
1.73
1.5
1.4
—
—
—
0
0
8
30
2.71
1.73
1.5
1.4
—
—
—
0
0
8
30
2.71
1.73
1.5
1.4
—
—
—
0
0
8
30
2.71
1.73
1.5
1.4
—
—
—
0
0
28
174
1.68
1.68
2.4
1.6
—
—
—
0
0
133
1126
1.35
1.68
6.7
5.5
27.68
28.37
%
0.29
127
1048
8
31
2.63
1.67
1.5
1.4
—
—
—
0
0
6
19
3.20
1.67
1.0
1.1
—
—
—
0
0
7
25
2.85
1.66
1.4
1.7
—
—
—
0
0
35
232
1.58
1.65
2.3
2.3
39.03
28.73
u/l
0.45
30
191
13
63
2.12
1.62
2.2
1.2
—
—
—
0
0
89
715
1.36
1.56
3.6
3.6
4.55
7.03
mg/mmol
0.47
48
415
95
772
1.35
1.55
3.4
2.7
31.62
31.26
u/l
0.04
89
740
74
578
1.38
1.54
2.4
2.1
2.72
3.35
mg/l
1.80
60
482
269
2602
2.17
1.53
25.7
20.5
38.98
39.65
%
0.90
247
2429
74
579
1.38
1.52
2.0
2.6
327.52
9105.86
umol/l
3.86
61
495
7
27
2.63
1.52
1.3
1.2
5.43
7.29
mmol/l
—
7
21
7
28
2.54
1.46
1.4
1.7
—
—
—
0
0
33
225
1.53
1.39
3.6
5.1
226.82
243.46
u/l
0.57
33
210
29
192
1.57
1.39
1.9
2.7
68.71
75.32
ng/l
0.29
24
167
156
1377
1.30
1.38
8.7
9.0
3.74
4.00
e9/l
0.96
150
1215
264
2538
1.86
1.38
12.1
10.3
25.22
24.03
u/l
0.40
259
2440
6
23
2.64
1.37
1.5
1.7
—
—
—
0
0
6
23
2.64
1.37
1.5
1.7
—
—
—
0
0
14
75
1.91
1.37
1.6
1.6
—
—
—
0
0
5
17
2.98
1.36
1.0
1.0
—
—
—
0
0
12
61
2.01
1.35
1.1
1.8
—
—
—
0
0
8
34
2.39
1.30
1.8
1.6
—
—
—
0
0
8
34
2.39
1.30
1.8
1.6
—
—
—
0
0
5
18
2.81
1.29
1.8
1.8
—
—
—
0
0
5
18
2.81
1.29
1.8
1.8
—
—
—
0
0
5
18
2.81
1.29
1.8
1.8
—
—
—
0
0
8
35
2.32
1.28
1.4
1.6
—
—
—
0
0
13
70
1.90
1.26
1.5
1.7
—
256.00
—
0
5
60
468
1.36
1.26
1.3
1.3
29.84
36.17
iu/ml
0.16
23
163
16
94
1.75
1.20
2.3
1.8
—
—
—
0
0
8
38
2.14
1.19
1.1
1.4
—
—
—
0
0
11
57
1.97
1.18
1.3
1.3
—
—
—
0
0
11
57
1.97
1.18
1.0
1.1
3.46
3.82
mmol/l
0.74
11
51
11
57
1.97
1.18
1.3
1.3
—
—
—
0
0
10
51
2.00
1.12
1.0
1.2
—
—
—
0
0
15
89
1.72
1.10
2.1
1.6
—
—
—
0
0
12
67
1.83
1.06
1.3
1.5
—
—
—
0
0
20
130
1.58
1.06
1.0
1.0
—
—
—
0
0
52
408
1.34
1.05
1.6
1.4
—
—
—
0
0
5
22
2.30
1.04
1.0
1.1
—
—
—
0
0
5
22
2.30
1.04
1.2
1.0
—
—
—
0
0
126
1115
1.24
0.98
6.7
5.2
56.44
57.12
%
0.26
121
1040
13
77
1.72
0.97
1.3
1.3
249.88
278.08
ug/g
—
8
42
7
37
1.91
0.94
1.6
1.2
53.48
19.00
u/l
—
7
30
6
27
2.25
0.94
1.0
1.6
—
—
—
0
0
16
105
1.56
0.83
1.7
2.3
0.58
0.68
%
1.47
16
105
245
2355
1.35
0.83
4.8
4.5
4.79
4.81
mmol/l
0.10
225
2171
17
244
0.68
0.79
2.1
3.5
—
—
—
0
0
235
2252
1.29
0.77
6.7
5.7
38.87
39.52
mmol/mol
0.55
221
2090
5
24
2.10
0.75
1.0
1.2
—
—
—
0
0
243
2342
1.31
0.73
4.9
4.4
1.62
1.57
mmol/l
0.85
227
2141
16
109
1.50
0.72
1.7
2.3
1.14
1.13
%
0.02
16
109
7
40
1.77
0.72
5.4
3.8
—
192.80
—
0
5
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
132
1204
1.18
0.69
4.3
3.8
0.00
0.01
estimate
—
6
207
13
86
1.54
0.67
1.8
1.2
—
—
—
0
0
18
129
1.42
0.65
1.7
1.4
—
—
—
0
0
100
898
1.18
0.62
2.9
3.1
2.34
2.36
mmol/l
0.86
85
780
8
50
1.62
0.62
1.6
1.6
—
—
—
0
0
8
50
1.62
0.62
1.6
1.6
—
—
—
0
0
13
88
1.50
0.61
1.8
1.1
—
—
—
0
0
130
1194
1.17
0.61
5.5
5.1
0.00
0.00
estimate
—
7
211
129
1185
1.17
0.60
4.3
3.8
0.00
0.00
estimate
—
7
231
8
52
1.55
0.60
1.6
1.5
—
—
—
0
0
14
196
0.70
0.60
2.1
1.7
—
—
—
0
0
59
510
1.20
0.56
1.6
1.7
527.57
467.46
pmol/l
0.67
51
414
10
65
1.56
0.56
1.1
1.2
404.70
471.10
mg/l
—
10
60
6
38
1.59
0.54
1.5
1.5
—
—
—
0
0
247
2403
1.26
0.53
5.6
5.1
2.74
2.82
mmol/l
0.69
229
2193
232
2249
1.19
0.48
4.3
4.0
1.27
1.26
mmol/l
0.09
210
2041
17
131
1.32
0.43
6.2
4.2
15.52
23.65
%
—
10
62
12
87
1.40
0.43
1.4
1.5
—
—
—
0
0
8
57
1.42
0.42
1.6
1.3
—
—
—
0
0
5
32
1.57
0.42
1.8
1.8
—
—
—
0
0
5
32
1.57
0.42
1.0
1.4
—
—
—
0
0
13
172
0.74
0.42
1.6
1.6
—
—
—
0
0
15
114
1.33
0.41
1.9
2.8
24.86
25.30
mmol/l
0.14
15
114
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
298.75
—
0
15
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
5
76
0.65
0.36
1.0
1.3
—
2.34
—
0
14
8
62
1.30
0.28
1.1
5.3
—
4.18
—
0
5
8
64
1.26
0.27
1.4
5.2
469.45
47.04
mg/l
—
8
48
8
64
1.26
0.27
1.4
5.2
19.64
24.46
mg/l
—
8
47
34
301
1.15
0.27
2.6
2.0
21.41
21.55
%
0.02
28
254
20
170
1.19
0.25
6.1
4.6
1.39
1.92
ug/l
0.50
20
143
6
84
0.71
0.24
1.0
1.7
—
—
—
0
0
8
102
0.78
0.21
1.4
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
9.12
—
0
11
0
10
0.00
0.21
0.0
4.0
—
208.00
—
0
10
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
8.11
—
0
12
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
49
454
1.10
0.20
1.2
1.3
1.17
11.91
u/ml
3.76
14
175
8
70
1.15
0.16
1.3
1.2
—
—
—
0
0
94
912
1.05
0.11
4.6
3.8
—
—
—
0
0
50
477
1.06
0.10
1.9
1.7
1342.82
1216.48
nmol/l
0.41
37
348
17
187
0.90
0.10
1.6
1.7
—
—
—
0
0
51
490
1.05
0.08
1.3
1.4
—
—
—
0
0
5
60
0.83
0.08
1.2
1.2
—
—
—
0
0
7
64
1.10
0.08
2.3
1.4
—
—
—
0
0
7
67
1.05
0.08
1.9
2.3
—
—
—
0
0
9
85
1.06
0.07
1.4
2.3
4.40
3.64
g/l
—
9
80
9
86
1.05
0.07
1.4
2.2
7.72
7.57
g/l
—
9
80
9
86
1.05
0.07
1.4
2.2
—
—
—
0
0
10
111
0.90
0.06
2.3
3.5
48.33
48.96
%
—
10
111
226
2270
0.98
0.02
14.2
13.0
78.28
79.07
ml/min/173m2
0.25
190
1846
10
93
1.08
0.02
1.9
1.4
—
—
—
0
0
28
286
0.98
0.00
2.2
3.7
29.33
6.11
ug/l
0.67
18
237
63
633
0.99
0.00
5.4
4.0
0.00
0.00
estimate
—
7
211
0
7
0.00
0.00
0.0
6.7
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
133.29
—
0
7
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
3.80
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
79
1.01
-0.00
1.3
2.3
2.93
3.08
g/l
—
8
73
0
6
0.00
-0.00
0.0
1.0
—
90.83
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
57
0.87
-0.00
1.2
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
103.78
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
10.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
25.90
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
109.20
—
0
5
7
74
0.94
-0.00
3.7
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
52.40
—
0
5
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_CUTLAXSEN and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_CUTLAXSEN | 0.901 [0.73, 1.12] | 0.345 |
| Birth year | 0.992 [0.98, 1.0] | 0.089 |
During the follow-up period (1.1.1998 — 31.12.2019), 91 out of 879 females with L12_CUTLAXSEN died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have L12_CUTLAXSEN.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.068% | No data |
| 5 | 0.471% | No data |
| 10 | 1.246% | No data |
| 15 | 2.254% | No data |
| 20 | 3.936% | No data |
Relationships between endpoints
↥Index endpoint: L12_CUTLAXSEN – Cutis laxa senilis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data